Skip to main content

Day: April 15, 2024

Allied Announces April 2024 Distribution

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.15 per unit for the month of April 2024, representing $1.80 per unit on an annualized basis. The distribution will be payable on May 15, 2024, to unitholders of record as at April 30, 2024. About Allied Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organizations with workspace that is sustainable and conducive to human wellness, creativity, connectivity and diversity. Allied’s vision is to make a continuous contribution to cities and culture that elevates and inspires the humanity in all people. FOR FURTHER INFORMATION, PLEASE CONTACT: Cecilia C. Williams, President and Chief...

Continue reading

FFW Corporation and Crossroads Bank Appoint New Board Member

WABASH, Ind., April 15, 2024 (GLOBE NEWSWIRE) — FFW Corporation (the “Corporation”) (OTC PINK: FFWC) and Crossroads Bank have announced the appointment of Kevin Hart to their Board of Directors. Dan Ford, Chairman of the Board, commented, “We are very excited to have Kevin join us as a director. His addition reflects the company’s commitment to adding accomplished leadership. His knowledge will help direct our continued success in the future.” Dr. Hart is a native of Kendallville, IN. He has practiced interventional cardiology since 1997, initially with Fort Wayne Cardiology and subsequently Parkview Health System. He serves on the Parkview Heart Institute Operating Council, where he helps with strategic and operational issues. Dr. Hart is also an enthusiastic supporter of American agriculture and is both avid farmland...

Continue reading

Verizon provides accessible, affordable and reliable connectivity options for those who need it most

New Verizon Forward offer brings home internet cost down to as low as $0 per month NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) — Verizon is committed to providing households with access to high-quality connectivity and reliable home internet without data caps, and does not believe that income should be a barrier to accessing it. Funding for the Affordable Connectivity Program, which has helped nearly 23 million households across the nation connect to the internet, is expected to end soon. However, Verizon’s commitment to keeping families connected will continue. Verizon Forward: Home Internet for as low as $20. Plus, new offer brings cost down to $0 per month1In 2020, we launched Verizon Forward to help customers access affordable and reliable broadband, and we will continue to offer the program to customers who qualify. Verizon...

Continue reading

Sannabis, Inc. (OTC: USPS) Posts Annual Disclosures on OTC Markets Group to Become Pink Current and Launches Large-Scale Cannabis Grow Operations in Colombia, Ahead of Introduction of a Marijuana Legalization Bill in the U.S. Senate

Global cannabis market projected to grow at GAGR of 34% to $444 Billion by 2030, from $57 Billion in 2023 CALI, Colombia, April 15, 2024 (GLOBE NEWSWIRE) — Sannabis, Inc. f/k/a Ultimate Sports, Inc. (OTC: USPS) (the ‘Company’), a Men’s Health services provider in the U.S., acquiring Sannabis S.A.S., a fully licensed prominent cannabis company in Colombia, announces the posting of current disclosures on the OTC Markets Group and the commencement of its expansive cannabis cultivation operations in Colombia. Sannabis entered into a contract with licensed growers, like themselves, and has begun the cultivation process to plant seedlings to produce high-quality CBD flower. Sannabis aims to meet the rising demand for premium cannabis products in the North and South American, European, and Asian markets. They are positioned to be a major...

Continue reading

Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement

HENDERSON, Nev., April 15, 2024 (GLOBE NEWSWIRE) — Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces the purchase of four technologies for production of three generic drugs in tablet form and one dietary supplement. The acquisition includes full dossiers for each product, which will allow NKPH to quickly register them for sale once the company has finalized the branding of each. The technologies, which were purchased through NKPH’s subsidiary, Nika Europe Ltd., have a proven market track record, as each of them satisfy an important health need of the population. The positive effect of each may be summarized as follows:VINPOCETINE 10mg is clinically tested and has been used for over thirty years for the treatment of stroke, dementia, and other brain disorders due to its neuroprotective abilities. Vinpocetine enhances memory...

Continue reading

Nova LifeStyle Announces Fiscal 2023 Results

LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial results for the fiscal year ended December 31, 2023. Tawny Lam, Chairperson and Chief Executive Officer of Nova LifeStyle, stated, “We are encouraged with the overall performance as we have improved our margins and increased sales volume throughout the entire year, although pricing pressure has been an issue. We believe some of the initiatives we took in the past, in which we discontinued operations that were not a good fit for us moving forward, should allow us at least to maintain our gross profit margins.” Financial Results for the Year Ended December 31, 2023:Net sales from continuing operations for the year ended December 31, 2023 were $11.09 million, a decrease of 13% from $12.74...

Continue reading

Kering: Information regarding the arrangements for taking part in the Combined General Meeting of April 25, 2024 and conditions for obtaining or consulting the documents prepared for the meeting

 Kering – Press release – Arrangements AGM April 25, 2024 – ENPRESS RELEASE  April 15, 2024INFORMATION REGARDING THE ARRANGEMENTS FOR TAKING PART IN THE COMBINED GENERAL MEETING OF APRIL 25, 2024 AND CONDITIONS FOR OBTAINING OR CONSULTINGTHE DOCUMENTS PREPARED FOR THE MEETING Kering shareholders are invited to attend the Company’s Combined General Meeting to be held at 3 p.m. on Thursday, April 25, 2024 (Paris time) at Kering’s headquarters – 40 rue de Sèvres, 75007 Paris, France. The General Meeting will be held in the physical presence of the shareholders and will also be broadcast live and available for replay on the Company’s website1: www.kering.com (Finance/Shareholders Information/Annual General Meeting section). The Preliminary Notice of Meeting, including the agenda, the proposed resolutions...

Continue reading

AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs

Charles W. Lapp, MDCharles W. Lapp, MDOCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced that Charles Lapp, MD, is joining the company to help lead its efforts to develop Ampligen (rintatolimod) as a potential treatment for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID. Dr. Lapp has played a key role in AIM’s long-standing AMP-511 Expanded Access Program for the treatment of ME/CFS and Long COVID, having founded one of the clinical trial’s key sites, the Hunter-Hopkins Center in Charlotte, N.C., from which he recently retired. As a Consulting Medical Officer and an independent contractor, he will help manage the company’s research programs related to ME/CFS and Long COVID, including the development of protocols and new clinical trials. Dr....

Continue reading

Brandywine Realty Trust Announces Tender Offer for Any and All of its Outstanding 4.10% Guaranteed Notes due 2024

PHILADELPHIA, April 15, 2024 (GLOBE NEWSWIRE) — Brandywine Realty Trust (the “Company”) (NYSE:BDN) announced today that its operating partnership, Brandywine Operating Partnership, L.P. (the “Operating Partnership”), has commenced a cash tender offer (the “Tender Offer”) for any and all of the $335,100,000 outstanding principal amount of its 4.10% Guaranteed Notes due October 1, 2024 (the “Notes”). Certain information regarding the Notes and the pricing for the Tender Offer is set forth in the table below.Title of Security CUSIP Number Principal AmountOutstanding U.S. TreasuryReference Security BloombergReference Page Fixed Spread4.10%Guaranteed NotesdueOctober 1, 2024 105340 AN3 $335,100,000 4.250%U.S. TreasurydueSeptember 30, 2024 FIT3 0 bps           The “Purchase Price” offered per $1,000 principal amount of Notes...

Continue reading

ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that the Company has entered into a proposed Securities Purchase Agreement (the “Agreement”) with Lophos Holdings Inc. (“Lophos”). Under the terms of the Agreement, Lophos will issue and sell 2,125,000 common shares (the “Purchased Lophos Shares”) and 2,125,000 common share purchase warrants (the “Purchased Lophos Warrants”, collectively the “Purchased Lophos Units”) to ThreeD at a price of $0.06 per Purchased Lophos Unit. Each Purchased Lophos Warrant will entitle the holder to purchase one common share of Lophos...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.